Swedish Orphan Biovitrum AB (publ) (BIOVF)
OTCMKTS
· Delayed Price · Currency is USD
30.50
-0.16 (-0.51%)
At close: May 2, 2025
BIOVF Market Cap
BIOVF has a market cap or net worth of $10.64 billion as of May 13, 2025. Its market cap has increased by 27.96% in one year.
Market Cap
10.64B
Enterprise Value
11.97B
Revenue
2.61B
Ranking
n/a
PE Ratio
26.96
Stock Price
$30.50
Market Cap Chart
Since September 15, 2006, BIOVF's market cap has increased from 663.04M to 10.64B, an increase of 1,504.04%. That is a compound annual growth rate of 16.02%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.63B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 712.65M |
| Tian'an Technology Group | 591.73M |
| CytoDyn | 510.85M |
| Glass House Brands | 479.77M |
| Elite Pharmaceuticals | 458.29M |
| Northwest Biotherapeutics | 413.23M |